All Pathways
Cardiothoracic SurgeryEmergency

Post-Cardiac Surgery Bleeding Management (EACTS 2024)

Post-Cardiac Surgery Bleeding Management (EACTS 2024): Post-Cardiac Surgery Bleeding → Assess Bleeding Severity → ⚠️ MASSIVE BLEEDING → Return to OR → B...

Interactive Decision Tree

Mini Map

Algorithm Steps

  1. Start

    Post-Cardiac Surgery Bleeding

    Elevated chest tube output or hemodynamic instability in post-op period

    1. Decision

      Assess Bleeding Severity

      Quantify chest tube output and clinical status

      • Measure chest tube output hourly
      • Trend hemoglobin/hematocrit
      • Assess hemodynamic stability
      • Check for signs of tamponade
      1. Warning

        ⚠️ MASSIVE BLEEDING

        >400 mL/hr or hemodynamic collapse

        • Activate massive transfusion protocol
        • Prepare for immediate re-exploration
        • Call cardiac surgery STAT
        1. Action

          Return to OR

          Surgical re-exploration

          • Median sternotomy re-opening
          • Evacuate clot
          • Identify and control surgical bleeding
          • Irrigate and reclose
          • Continue hemostatic resuscitation
          1. Outcome

            Bleeding Controlled

            Continue routine post-op care

        2. Warning

          ⚠️ Rule Out Tamponade

          Sudden drop in chest tube output + hypotension = assume tamponade until proven otherwise

      2. Action

        Significant Bleeding

        >200 mL/hr for 2+ hours

        • Check chest tubes for patency - milk gently
        • Warm patient to 37°C
        • Correct acidosis
        • Obtain coagulation labs + viscoelastic test
        1. Action

          Coagulation Assessment

          Use viscoelastic testing if available

          • TEG or ROTEM preferred over conventional tests
          • Check: PT/INR, aPTT, fibrinogen, platelets
          • Consider heparin rebound (protamine re-dose)
          • Assess platelet function if on antiplatelet agents
          1. Action

            Correct Coagulopathy

            Guided by TEG/ROTEM or conventional labs

            • Fibrinogen <1.5 g/L: Fibrinogen concentrate or cryoprecipitate
            • Platelets <100 × 10⁹/L: Platelet transfusion
            • INR >1.5: PCC or FFP (PCC preferred)
            • Heparin rebound: Protamine 25-50 mg
            • Consider desmopressin (DDAVP) 0.3 mcg/kg
            • Tranexamic acid if ongoing fibrinolysis
            1. Decision

              Re-exploration Indicated?

              Assess need for surgical intervention

              • Indications for re-exploration:
              • • >400 mL in first hour
              • • >200 mL/hr for 4 hours despite correction
              • • Sudden cessation of drainage (clot)
              • • Hemodynamic instability
              • • Signs of tamponade
              1. Action

                Continue Medical Management

                If bleeding controlled with correction

                • Serial hemoglobin monitoring (q2-4h)
                • Continue warming
                • Maintain Hb >7-8 g/dL (>8-9 if ongoing bleeding)
                • Watch for delayed tamponade
            2. Action

              Transfusion Targets

              Restrictive approach when stable

              • Hemoglobin trigger: 7-8 g/dL (stable)
              • Higher threshold if active bleeding/ischemia
              • Avoid over-transfusion (increased complications)
              • Use cell salvage when available
      3. Action

        Moderate Bleeding

        100-200 mL/hr

        • Monitor closely
        • Check coagulation status
        • Optimize temperature and pH
        • Review anticoagulation status

Guideline Source

EACTS/EACTAIC Guidelines on Patient Blood Management in Adult Cardiac Surgery 2024

Clinical Safety Information

Clinical Decision Support — Not a Substitute for Clinical Judgment

Individual patient factors may require deviation from these recommendations.

Known Limitations

  • Thresholds may vary by institution
  • Requires access to viscoelastic testing (TEG/ROTEM) for optimal management
  • Does not address pediatric cardiac surgery
  • Anticoagulation management in specific valve types requires specialist input

Applicable Regions

USEU
Version 1Next review: 2027-01-11

Frequently Asked Questions

What is the Post-Cardiac Surgery Bleeding Management (EACTS 2024)?

The Post-Cardiac Surgery Bleeding Management (EACTS 2024) is a emergency clinical algorithm for Cardiothoracic Surgery. It provides a structured decision tree to guide clinical decision-making, based on EACTS/EACTAIC Guidelines on Patient Blood Management in Adult Cardiac Surgery 2024.

What guideline is the Post-Cardiac Surgery Bleeding Management (EACTS 2024) based on?

This algorithm is based on EACTS/EACTAIC Guidelines on Patient Blood Management in Adult Cardiac Surgery 2024 (DOI: 10.1093/ejcts/ezae352).

What are the limitations of the Post-Cardiac Surgery Bleeding Management (EACTS 2024)?

Known limitations include: Thresholds may vary by institution; Requires access to viscoelastic testing (TEG/ROTEM) for optimal management; Does not address pediatric cardiac surgery; Anticoagulation management in specific valve types requires specialist input. Individual patient factors may require deviation from these recommendations.

Get AI-Powered Analysis Alongside This Algorithm

In AttendMe.ai, the Post-Cardiac Surgery Bleeding Management (EACTS 2024) appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.

Try AttendMe Free